Home
ELAB
ELAB News

Latest Elevai Labs Inc. (ELAB) News on February 22, 2025

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 Receptor Agonists

GlobeNewswire

4 days ago

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 Receptor Agonists

Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1

GlobeNewswire

18 days ago

Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1

PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies

GlobeNewswire

22 days ago

PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Signs Agreement For Preclinical Mouse Study of EL-32, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1

GlobeNewswire

23 days ago

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Signs Agreement For Preclinical Mouse Study of EL-32, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1

PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional Investors

GlobeNewswire

a month ago

PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional Investors

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity Symposium

GlobeNewswire

a month ago

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity Symposium

PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture

GlobeNewswire

a month ago

PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture

PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries

GlobeNewswire

a month ago

PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries

PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy

GlobeNewswire

2 months ago

PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy

Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products

GlobeNewswire

2 months ago

Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products

Elevai Labs plans name change to PMGC Holdings, redomicile to Nevada

TipRanks

2 months ago

Elevai Labs plans name change to PMGC Holdings, redomicile to Nevada

Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada

GlobeNewswire

2 months ago

Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada

Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to Nevada

GlobeNewswire

2 months ago

Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to Nevada

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Announces FDA Regulatory Pathway for EL-22, a Pioneering Obesity Therapy Targeting Fat Loss and Muscle Preservation

GlobeNewswire

2 months ago

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Announces FDA Regulatory Pathway for EL-22, a Pioneering Obesity Therapy Targeting Fat Loss and Muscle Preservation

Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market

GlobeNewswire

3 months ago

Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market

Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division

GlobeNewswire

3 months ago

Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division

Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance

GlobeNewswire

3 months ago

Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance

Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to Reassess

GlobeNewswire

3 months ago

Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to Reassess

Elevai Labs Third Quarter 2024 Earnings: US$0.068 loss per share (vs US$0.078 loss in 3Q 2023)

Simply Wall St.

3 months ago

Elevai Labs Third Quarter 2024 Earnings: US$0.068 loss per share (vs US$0.078 loss in 3Q 2023)

CORRECTION - Elevai Labs Inc.

GlobeNewswire

3 months ago

CORRECTION - Elevai Labs Inc.

Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update

GlobeNewswire

3 months ago

Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update

Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange

GlobeNewswire

4 months ago

Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity

GlobeNewswire

4 months ago

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity

GlobeNewswire

4 months ago

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity

Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock

GlobeNewswire

5 months ago

Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock

MT Newswires

5 months ago

Sector Update: Health Care Stocks Fall Late Afternoon

REPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations

GlobeNewswire

5 months ago

REPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations

MT Newswires

5 months ago

Top Midday Gainers

MT Newswires

5 months ago

Elevai Labs Unit Seeks Patents for Lead Drug Candidate to Treat Muscle Loss in Obese Patients

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations

GlobeNewswire

5 months ago

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy Device

GlobeNewswire

5 months ago

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy Device

Altium Capital Management LP Acquires New Stake in Elevai Labs Inc

GuruFocus.com

5 months ago

Altium Capital Management LP Acquires New Stake in Elevai Labs Inc

MT Newswires

5 months ago

Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday

MT Newswires

5 months ago

Elevai Labs Closes $8 Million Securities Offering; Shares Rise After Hours

Univest Securities, LLC Announces Closing of $8.0 Million Registered Follow-on Offering for its Client Elevai Labs Inc. (NASDAQ: ELAB)

GlobeNewswire

5 months ago

Univest Securities, LLC Announces Closing of $8.0 Million Registered Follow-on Offering for its Client Elevai Labs Inc. (NASDAQ: ELAB)

MT Newswires

5 months ago

Top Midday Decliners

MT Newswires

5 months ago

Elevai Labs Prices $8 Million Public Offering; Shares Fall Pre-Bell

Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering

GlobeNewswire

5 months ago

Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Results for E-Series Exosome Technology in Potential Melasma Applications

GlobeNewswire

5 months ago

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Results for E-Series Exosome Technology in Potential Melasma Applications

MT Newswires

6 months ago

Elevai Labs Says Study of Exosome Technology Shows Reversal of Hair Thinning; Shares Rise Pre-Bell

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome Technology

GlobeNewswire

6 months ago

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome Technology

MT Newswires

6 months ago

Elevai Labs, Yuva Biosciences File 2 Hair Treatment Patents

Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™

GlobeNewswire

6 months ago

Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™

MT Newswires

6 months ago

Elevai Labs Reports Skin Improvement in Exosome Study -- Shares Jump Pre-Bell

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai Enfinity™ Topical Exosome Serum

GlobeNewswire

6 months ago

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai Enfinity™ Topical Exosome Serum

Elevai Labs Second Quarter 2024 Earnings: US$0.077 loss per share (vs US$0.13 loss in 2Q 2023)

Simply Wall St.

6 months ago

Elevai Labs Second Quarter 2024 Earnings: US$0.077 loss per share (vs US$0.13 loss in 2Q 2023)

Elevai Labs Inc. Subsidiary, Elevai Research Inc., Announces Preliminary Positive Research Data Highlighting the Potential of Proprietary Exosome Technology for Skin Health Applications

GlobeNewswire

6 months ago

Elevai Labs Inc. Subsidiary, Elevai Research Inc., Announces Preliminary Positive Research Data Highlighting the Potential of Proprietary Exosome Technology for Skin Health Applications

Elevai Labs Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

6 months ago

Elevai Labs Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update

Elevai Labs Inc. Subsidiary, Elevai Biosciences, Continues to Advance its Scientific Advisory Board with the Appointment of Orian Shirihai, MD, PhD

GlobeNewswire

7 months ago

Elevai Labs Inc. Subsidiary, Elevai Biosciences, Continues to Advance its Scientific Advisory Board with the Appointment of Orian Shirihai, MD, PhD

Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Product Line

GlobeNewswire

8 months ago

Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Product Line

Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024

GlobeNewswire

8 months ago

Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024

Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs

GlobeNewswire

8 months ago

Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs

Better AI Stock: Palantir vs. Snowflake

Motley Fool

8 months ago

Better AI Stock: Palantir vs. Snowflake

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

Motley Fool

8 months ago

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

BigBear.ai Stock: Buy, Sell, or Hold?

Motley Fool

8 months ago

BigBear.ai Stock: Buy, Sell, or Hold?

Indonesia's first Olympic gymnast encourages others to 'dream higher'

AFP

8 months ago

Indonesia's first Olympic gymnast encourages others to 'dream higher'

Where Will CrowdStrike Stock Be in 1 Year?

Motley Fool

8 months ago

Where Will CrowdStrike Stock Be in 1 Year?

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

GuruFocus.com

8 months ago

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

GuruFocus.com

8 months ago

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)

Simply Wall St.

8 months ago

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)

Elevai Labs Subsidiary, Elevai Skincare, to Present at the Beauty Through Science Conference in Stockholm

GlobeNewswire

9 months ago

Elevai Labs Subsidiary, Elevai Skincare, to Present at the Beauty Through Science Conference in Stockholm

Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference

GlobeNewswire

9 months ago

Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference

Elevai Labs Inc. Reports First Quarter 2024 Financial Results

GlobeNewswire

9 months ago

Elevai Labs Inc. Reports First Quarter 2024 Financial Results

Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity

GlobeNewswire

10 months ago

Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity

Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare

GlobeNewswire

10 months ago

Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare

Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments

GlobeNewswire

10 months ago

Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments

Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments

GlobeNewswire

10 months ago

Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments

MT Newswires

10 months ago

Elevai Labs Signs Exclusive Distribution Deal for Taiwan

ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months

GlobeNewswire

10 months ago

ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months

Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results

GlobeNewswire

a year ago

Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results

Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market

GlobeNewswire

a year ago

Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market

Tortoise Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of January 31, 2024, for TYG, NTG, TTP, NDP and TPZ

ACCESSWIRE

a year ago

Tortoise Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of January 31, 2024, for TYG, NTG, TTP, NDP and TPZ

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 02/01/2024

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 01/31/2024

Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices

PR Newswire

a year ago

Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices

OneMedNet Announces Participation as an Exhibitor at the 15ᵗʰ Annual SCOPE Summit

GlobeNewswire

a year ago

OneMedNet Announces Participation as an Exhibitor at the 15ᵗʰ Annual SCOPE Summit

Nortech Systems Expands Fiber Optic Capabilities with Innovative Expanded Beam XtremeTM Technology

Business Wire

a year ago

Nortech Systems Expands Fiber Optic Capabilities with Innovative Expanded Beam XtremeTM Technology

ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office

GlobeNewswire

a year ago

ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office

PetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent Application

GlobeNewswire

a year ago

PetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent Application

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer

Business Wire

a year ago

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer

Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026

GlobeNewswire

a year ago

Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026

Orion (OESX) Preliminary Q3 Results Depict Strong Demand

Zacks

a year ago

Orion (OESX) Preliminary Q3 Results Depict Strong Demand

Ikena Oncology to lay off 35% of staff

BioPharma Dive

a year ago

Ikena Oncology to lay off 35% of staff

Home Federal Bancorp, Inc. of Louisiana Declares Quarterly Cash Dividend

GlobeNewswire

a year ago

Home Federal Bancorp, Inc. of Louisiana Declares Quarterly Cash Dividend

Ikena Oncology Outlines Key Priorities and Provides Corporate Updates

GlobeNewswire

a year ago

Ikena Oncology Outlines Key Priorities and Provides Corporate Updates

iCoreConnect Inc. Announces Expansion of Endorsement Collaboration With the Rhode Island Dental Association

GlobeNewswire

a year ago

iCoreConnect Inc. Announces Expansion of Endorsement Collaboration With the Rhode Island Dental Association

Vintage Wine Estates Restructures Organization, Initiates Cost Cuts and Simplifies Business Model

Business Wire

a year ago

Vintage Wine Estates Restructures Organization, Initiates Cost Cuts and Simplifies Business Model

ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach

GlobeNewswire

a year ago

ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach

Alternus Clean Energy Retires $10 Million of Convertible Debt

GlobeNewswire

a year ago

Alternus Clean Energy Retires $10 Million of Convertible Debt

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology

GlobeNewswire

a year ago

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology

(Updated) U.S. Legal Cannabis Pioneer Bright Green Corporation Appoints Industry Veteran Groovy Singh as New Chief Executive Officer

GlobeNewswire

a year ago

(Updated) U.S. Legal Cannabis Pioneer Bright Green Corporation Appoints Industry Veteran Groovy Singh as New Chief Executive Officer

New Multi-Hospital Partner Joins OneMedNet's Expansive Real World Data Network

ACCESSWIRE

a year ago

New Multi-Hospital Partner Joins OneMedNet's Expansive Real World Data Network

Knightscope Deploys Four New Security Robots at Three Locations

Business Wire

a year ago

Knightscope Deploys Four New Security Robots at Three Locations

Global airport operator Fraport and Lilium to collaborate on development of commercial eVTOL network

GlobeNewswire

a year ago

Global airport operator Fraport and Lilium to collaborate on development of commercial eVTOL network

U.S. Energy Corp. Announces Completion of Asset Divestitures and Provides Liquidity Update

GlobeNewswire

a year ago

U.S. Energy Corp. Announces Completion of Asset Divestitures and Provides Liquidity Update

iCoreConnect Inc. Announces Strategic Acquisition of Verifi Dental

NewMediaWire

a year ago

iCoreConnect Inc. Announces Strategic Acquisition of Verifi Dental

Alternus Clean Energy to Participate in Water Tower Research Fireside Chat Series

GlobeNewswire

a year ago

Alternus Clean Energy to Participate in Water Tower Research Fireside Chat Series

Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity

PR Newswire

a year ago

Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity

Knightscope Receives New Orders from City Hall and Growing Reseller

Business Wire

a year ago

Knightscope Receives New Orders from City Hall and Growing Reseller

bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

ACCESSWIRE

a year ago

bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

Share on Social Networks: